RecruitingPhase 2NCT06053164

Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease

Studying Interstitial lung disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Alberta
Principal Investigator
Mike Stickland
University of Alberta
Intervention
Exertional Oxygen(drug)
Enrollment
60 target
Eligibility
18-85 years · All sexes
Timeline
20252026

Study locations (1)

Collaborators

Alberta Boehringer Ingelheim Collaboration

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06053164 on ClinicalTrials.gov

Other trials for Interstitial lung disease

Additional recruiting or active studies for the same condition.

See all trials for Interstitial lung disease

← Back to all trials